ArticleDisease markers2022

C1R, CCL2, and TNFRSF1A Genes in Coronavirus Disease-COVID-19 Pathway Serve as Novel Molecular Biomarkers of GBM Prognosis and Immune Infiltration.

Xianggang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.